Solana Company posts $30.3M quarterly loss as digital assets weigh on results

The Nasdaq-listed company, formerly known as Helius Medical Technologies, reported a sharp revenue increase compared to the same period last year when earnings were just $43,000. However, this growth failed to offset significant operating expenses, which surged to $35.1 million from $3.3 million a year earlier. Administrative costs were also inflated by $6.8 million in severance payments related to the divestiture of its legacy PoNS medical-device business.

While the company successfully restaked 31,200 SOL during the quarter to maintain its treasury, total assets on its balance sheet declined to $176.1 million from $303.9 million at the end of 2025. Cash reserves also tightened, falling to $3.6 million. Management is now pivoting toward infrastructure services, specifically its Pacific Backbone initiative, which launched a validator cluster in Tokyo. CEO Joseph Chee stated that the company expects this institutional-grade operation to begin contributing third-party revenue in the third quarter, supported by a recent commitment of 500,000 SOL from external partners.